Mirabegron and Sitagliptin phosphate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mirabegron (mirabegron) and Sitagliptin phosphate (sitagliptin phosphate). Common drug interactions include renal impairment among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Mirabegron and Sitagliptin phosphate. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.

What is Sitagliptin phosphate?

Sitagliptin phosphate has active ingredients of sitagliptin phosphate. eHealthMe is studying from 3,787 Sitagliptin phosphate users. Check the latest studies of Sitagliptin phosphate.

On Jul, 18, 2026

16 people who take Mirabegron and Sitagliptin phosphate together, and have interactions are studied.

Mirabegron and Sitagliptin phosphate drug interactions.

What are the common drug interactions of Mirabegron and Sitagliptin Phosphate, by gender? *:

female:

Renal impairment (severely reduced kidney function)
Venous thrombosis limb (blood clot that forms in a vein in the limb)
Arthralgia (joint pain)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Hyperglycaemia (high blood sugar)
Hypertension (high blood pressure)
Limb discomfort (discomfort in leg)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Pain
Peripheral swelling

male:

Febrile neutropenia (fever with reduced white blood cells)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Disuse syndrome (deterioration of body systems as a result of prescribed or unavoidable inactivity)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Marasmus (severe malnutrition characterized by energy deficiency)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Performance status decreased

What are the common drug interactions of Mirabegron and Sitagliptin Phosphate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Acidosis (build-up of carbon dioxide in the blood)
Back pain
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Diarrhoea
Hypersensitivity
Infusion site rash
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Rash
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

60+:

Cardiac failure
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Bacterial test positive
Brain natriuretic peptide increased
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Disuse syndrome (deterioration of body systems as a result of prescribed or unavoidable inactivity)

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 31.25%
Diabetes: 5 people, 31.25%
Dementia (madness): 5 people, 31.25%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 5 people, 31.25%
Asthma: 4 people, 25.00%
Pneumonia: 4 people, 25.00%
Osteoporosis (bones weak and more likely to break): 4 people, 25.00%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 25.00%
Constipation: 4 people, 25.00%
Hyperglycemia (high blood sugar): 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mirabegron and Sitagliptin phosphate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously